SCOPUS 정보 검색 플랫폼

Volumn 127, Issue 1, 2011, Pages 287-296

Risk of ipsilateral breast cancer in BRCA1 and BRCA2 mutation carriers

(13) Metcalfe, Kelly a,b Lynch, Henry T c Ghadirian, Parviz d Tung, Nadine e Kim Sing, Charmaine f Olopade, Olufunmilayo I g Domchek, Susan h Eisen, Andrea i Foulkes, William D j Rosen, Barry k Vesprini, Danny i Sun, Ping b Narod, Steven A b

a UNIVERSITY OF TORONTO (Canada)

b WOMEN S COLLEGE HOSPITAL (Canada)

c CREIGHTON UNIVERSITY SCHOOL OF MEDICINE (United States)

d CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL (Canada)

e BETH ISRAEL DEACONESS MEDICAL CENTER (United States)

f BRITISH COLUMBIA CANCER AGENCY (Canada)

g UNIVERSITY OF CHICAGO (United States)

h UNIVERSITY OF PENNSYLVANIA (United States)

i DEPARTMENT OF RADIATION ONCOLOGY (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; TAMOXIFEN;

ADULT; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; FOLLOW UP; GENE MUTATION; HUMAN; IPSILATERAL BREAST CANCER; MAJOR CLINICAL STUDY; OVARIECTOMY; PARTIAL MASTECTOMY; PRIORITY JOURNAL; RISK REDUCTION; TUMOR SUPPRESSOR GENE;

ADULT; AGED; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; MIDDLE AGED; MUTATION; NORTH AMERICA; PROGNOSIS; RISK FACTORS; YOUNG ADULT;

EID: 79954772253 PISSN: 01676806 EISSN: 15737217 Source Type: Journal
DOI: 10.1007/s10549-010-1336-7 Document Type: Article

Times cited : (71)

References (34)

1
- 0038744296
- Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: A combined analysis of 22 studies
- DOI 10.1086/375033
- A Antoniou PD Pharoah S Narod 2003 Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies Am J Hum Genet 72 1117 1130 12677558 10.1086/375033 1:CAS:528:DC%2BD3sXjslagtbg%3D (Pubitemid 36530000)
- (2003) American Journal of Human Genetics , vol.72 , Issue.5 , pp. 1117-1130
- Antoniou, A.¹ Pharoah, P.D.P.² Narod, S.³ Risch, H.A.⁴ Eyfjord, J.E.⁵ Hopper, J.L.⁶ Loman, N.⁷ Olsson, H.⁸ Johannsson, O.⁹ Borg, A.¹⁰ Pasini, B.¹¹ Radice, P.¹² Manoukian, S.¹³ Eccles, D.M.¹⁴ Tang, N.¹⁵ Olah, E.¹⁶ Anton-Culver, H.¹⁷ Warner, E.¹⁸ Lubinski, J.¹⁹ Gronwald, J.²⁰ more..

2
- 34248170114
- Meta-analysis of BRCA1 and BRCA2 penetrance
- DOI 10.1200/JCO.2006.09.1066
- S Chen G Parmigiani 2007 Meta-analysis of BRCA1 and BRCA2 penetrance J Clin Oncol 25 1329 1333 17416853 10.1200/JCO.2006.09.1066 (Pubitemid 46706879)
- (2007) Journal of Clinical Oncology , vol.25 , Issue.11 , pp. 1329-1333
- Chen, S.¹ Parmigiani, G.²

3
- 17344392776
- Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1
- DOI 10.1016/S0140-6736(97)07065-7
- LC Verhoog CT Brekelmans C Seynaeve, et al. 1998 Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1 Lancet 351 316 321 9652611 10.1016/S0140-6736(97)07065-7 1:STN:280: DyaK1czhsVOiuw%3D%3D (Pubitemid 28052696)
- (1998) Lancet , vol.351 , Issue.9099 , pp. 316-321
- Verhoog, L.C.¹ Brekelmans, C.T.M.² Seynaeve, C.³ Van Den Bosch, L.M.C.⁴ Dahmen, G.⁵ Van Geel, A.N.⁶ Tilanus-Linthorst, M.M.A.⁷ Bartels, C.C.M.⁸ Wagner, A.⁹ Van Den Ouweland, A.¹⁰ Devilee, P.¹¹ Meijers-Heijboer, E.J.¹² Klijn, J.G.M.¹³

4
- 0031860462
- BRCA-associated breast cancer in young women
- 9586873 1:STN:280:DyaK1c3ks1artw%3D%3D
- M Robson T Gilewski B Haas, et al. 1998 BRCA-associated breast cancer in young women J Clin Oncol 16 1642 1649 9586873 1:STN:280:DyaK1c3ks1artw%3D%3D
- (1998) J Clin Oncol , vol.16 , pp. 1642-1649
- Robson, M.¹ Gilewski, T.² Haas, B.³

5
- 0033949548
- Contralateral breast cancer risk is influenced by the age at onset in BRCA1-associated breast cancer
- LC Verhoog CT Brekelmans C Seynaeve, et al. 2000 Contralateral breast cancer risk is influenced by the age at onset in BRCA1-associated breast cancer Br J Cancer 83 384 386 10917555 10.1054/bjoc.2000.1239 1:STN:280: DC%2BD3cznt1ahsQ%3D%3D (Pubitemid 30453580)
- (2000) British Journal of Cancer , vol.83 , Issue.3 , pp. 384-386
- Verhoog, L.C.¹ Brekelmans, C.T.M.² Seynaeve, C.³ Meijers-Heijboer, E.J.⁴ Klijn, J.G.M.⁵

6
- 0037181697
- Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status
- DOI 10.1016/S0140-6736(02)08434-9
- BG Haffty E Harrold AJ Khan, et al. 2002 Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status Lancet 359 1471 1477 11988246 10.1016/S0140-6736(02)08434-9 (Pubitemid 34457765)
- (2002) Lancet , vol.359 , Issue.9316 , pp. 1471-1477
- Haffty, B.G.¹ Harrold, E.² Khan, A.J.³ Pathare, P.⁴ Smith, T.E.⁵ Turner, B.C.⁶ Glazer, P.M.⁷ Ward, B.⁸ Carter, D.⁹ Matloff, E.¹⁰ Bale, A.E.¹¹ Alvarez-Franco, M.¹²

7
- 33847668823
- Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2-, BRCA1- and non-BRCA1/2 families as compared to sporadic breast cancer cases
- DOI 10.1016/j.ejca.2006.12.009, PII S0959804906010707
- CT Brekelmans MM Tilanus-Linthorst C Seynaeve, et al. 2007 Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2-, BRCA1- and non-BRCA1/2 families as compared to sporadic breast cancer cases Eur J Cancer 43 867 876 17307353 10.1016/j.ejca.2006.12.009 1:CAS:528:DC%2BD2sXisleitLw%3D (Pubitemid 46366688)
- (2007) European Journal of Cancer , vol.43 , Issue.5 , pp. 867-876
- Brekelmans, C.T.M.¹ Tilanus-Linthorst, M.M.A.² Seynaeve, C.³ Ouweland, A.⁴ Menke-Pluymers, M.B.E.⁵ Bartels, C.C.M.⁶ Kriege, M.⁷ Van Geel, A.N.⁸ Burger, C.W.⁹ Eggermont, A.M.M.¹⁰ Meijers-Heijboer, H.¹¹ Klijn, J.G.M.¹²

8
- 73349132056
- Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers
- 19858402 10.1200/JCO.2008.19.9430
- MK Graeser C Engel K Rhiem, et al. 2009 Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers J Clin Oncol 27 5887 5892 19858402 10.1200/JCO.2008.19.9430
- (2009) J Clin Oncol , vol.27 , pp. 5887-5892
- Graeser, M.K.¹ Engel, C.² Rhiem, K.³

9
- 2942739225
- Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
- DOI 10.1200/JCO.2004.04.033
- K Metcalfe HT Lynch P Ghadirian, et al. 2004 Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers J Clin Oncol 22 2328 2335 15197194 10.1200/JCO.2004.04.033 1:CAS:528:DC%2BD2cXpsVWltbs%3D (Pubitemid 41115389)
- (2004) Journal of Clinical Oncology , vol.22 , Issue.12 , pp. 2328-2335
- Metcalfe, K.¹ Lynch, H.T.² Ghadirian, P.³ Tung, N.⁴ Olivotto, I.⁵ Warner, E.⁶ Olopade, O.I.⁷ Eisen, A.⁸ Weber, B.⁹ McLennan, J.¹⁰ Sun, P.¹¹ Foulkes, W.D.¹² Narod, S.A.¹³

10
- 79954950304
- (submitted)
- Metcalfe K, Gershman S, Lynch HT et al Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers (submitted)
- Predictors of Contralateral Breast Cancer in BRCA1 and BRCA2 Mutation Carriers
- Metcalfe, K.¹ Gershman, S.² Lynch, H.T.³

11
- 33644700937
- Survival and prognostic factors in BRCA1-associated breast cancer
- DOI 10.1093/annonc/mdj095
- CT Brekelmans C Seynaeve M Menke-Pluymers, et al. 2006 Survival and prognostic factors in BRCA1-associated breast cancer Ann Oncol 17 391 400 16322115 10.1093/annonc/mdj095 1:STN:280:DC%2BD287ht1OksQ%3D%3D (Pubitemid 43329574)
- (2006) Annals of Oncology , vol.17 , Issue.3 , pp. 391-400
- Brekelmans, C.T.M.¹ Seynaeve, C.² Menke-Pluymers, M.³ Bruggenwirth, H.T.⁴ Tilanus-Linthorst, M.M.A.⁵ Bartels, C.C.M.⁶ Kriege, M.⁷ Van Geel, A.N.⁸ Crepin, C.M.G.⁹ Blom, J.C.¹⁰ Meijers-Heijboer, H.¹¹ Klijn, J.G.M.¹²

12
- 11144358484
- Ipsilateral breast tumour recurrence in hereditary breast cancer following breast-conserving therapy
- DOI 10.1016/j.ejca.2004.01.017, PII S0959804904001261
- C Seynaeve LC Verhoog LM van de Bosch, et al. 2004 Ipsilateral breast tumour recurrence in hereditary breast cancer following breast-conserving therapy Eur J Cancer 40 1150 1158 15110878 10.1016/j.ejca.2004.01.017 1:STN:280:DC%2BD2c3ht1yrsQ%3D%3D (Pubitemid 38526333)
- (2004) European Journal of Cancer , vol.40 , Issue.8 , pp. 1150-1158
- Seynaeve, C.¹ Verhoog, L.C.² Van De Bosch, L.M.C.³ Van Geel, A.N.⁴ Menke-Pluymers, M.⁵ Meijers-Heijboer, E.J.⁶ Van Den Ouweland, A.M.W.⁷ Wagner, A.⁸ Creutzberg, C.L.⁹ Niermeijer, M.F.¹⁰ Klijn, J.G.M.¹¹ Brekelmans, C.T.M.¹²

13
- 85010791733
- A combined analysis of outcome following breast cancer: Differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment
- 14680495 10.1186/bcr658 1:CAS:528:DC%2BD2cXnsl2hsw%3D%3D
- ME Robson PO Chappuis J Satagopan, et al. 2004 A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment Breast Cancer Res 6 R8 R17 14680495 10.1186/bcr658 1:CAS:528:DC%2BD2cXnsl2hsw%3D%3D
- (2004) Breast Cancer Res , vol.6
- Robson, M.E.¹ Chappuis, P.O.² Satagopan, J.³

14
- 10844296769
- Appropriateness of breast-conserving treatment of breast carcinoma in women with germline mutations in BRCA1 or BRCA2: A clinic-based series
- DOI 10.1002/cncr.20728
- M Robson T Svahn B McCormick, et al. 2005 Appropriateness of breast-conserving treatment of breast carcinoma in women with germline mutations in BRCA1 or BRCA2: a clinic-based series Cancer 103 44 51 15558796 10.1002/cncr.20728 (Pubitemid 39665455)
- (2005) Cancer , vol.103 , Issue.1 , pp. 44-51
- Robson, M.¹ Svahn, T.² McCormick, B.³ Borgen, P.⁴ Hudis, C.A.⁵ Norton, L.⁶ Offit, K.⁷

15
- 33744988630
- Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer
- DOI 10.1200/JCO.2005.02.7888
- LJ Pierce AM Levin TR Rebbeck, et al. 2006 Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer J Clin Oncol 24 2437 2443 16636335 10.1200/JCO.2005.02. 7888 (Pubitemid 46630619)
- (2006) Journal of Clinical Oncology , vol.24 , Issue.16 , pp. 2437-2443
- Pierce, L.J.¹ Levin, A.M.² Rebbeck, T.R.³ Ben-David, M.A.⁴ Friedman, E.⁵ Solin, L.J.⁶ Harris, E.E.⁷ Gaffney, D.K.⁸ Haffty, B.G.⁹ Dawson, L.A.¹⁰ Narod, S.A.¹¹ Olivotto, I.A.¹² Eisen, A.¹³ Whelan, T.J.¹⁴ Olopade, O.I.¹⁵ Isaacs, C.¹⁶ Merajver, S.D.¹⁷ Wong, J.S.¹⁸ Garber, J.E.¹⁹ Weber, B.L.²⁰ more..

16
- 0035774097
- Familial breast cancer: An investigation into the outcome of treatment for early stage disease
- DOI 10.1023/A:1013867917101
- D Eccles P Simmonds J Goddard, et al. 2001 Familial breast cancer: an investigation into the outcome of treatment for early stage disease Fam Cancer 1 65 72 14573999 10.1023/A:1013867917101 1:STN:280:DC%2BD3svps1Sgtw%3D%3D (Pubitemid 35221517)
- (2001) Familial Cancer , vol.1 , Issue.2 , pp. 65-72
- Eccles, D.¹ Simmonds, P.² Goddard, J.³ Coultas, M.⁴ Hodgson, S.⁵ Lalloo, F.⁶ Evans, G.⁷ Haites, N.⁸

17
- 0013886848
- A biostatistical study of locally recurrent breast carcinoma
- 5908662 1:STN:280:DyaF287gslaqsQ%3D%3D
- WL Donegan CM Perez-Mesa FR Watson 1966 A biostatistical study of locally recurrent breast carcinoma Surg Gynecol Obstet 122 529 540 5908662 1:STN:280:DyaF287gslaqsQ%3D%3D
- (1966) Surg Gynecol Obstet , vol.122 , pp. 529-540
- Donegan, W.L.¹ Perez-Mesa, C.M.² Watson, F.R.³

18
- 77953028921
- Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: Comparison of breast conservation and mastectomy
- 20411323 10.1007/s10549-010-0894-z
- LJ Pierce KA Phillips KA Griffith, et al. 2010 Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomy Breast Cancer Res Treat 121 389 398 20411323 10.1007/s10549-010-0894-z
- (2010) Breast Cancer Res Treat , vol.121 , pp. 389-398
- Pierce, L.J.¹ Phillips, K.A.² Griffith, K.A.³

19
- 77956193440
- Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality
- 20810374 10.1001/jama.2010.1237 1:CAS:528:DC%2BC3cXhtFWjsbrF
- SM Domchek TM Friebel CF Singer 2010 Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality JAMA 304 967 975 20810374 10.1001/jama.2010.1237 1:CAS:528:DC%2BC3cXhtFWjsbrF
- (2010) JAMA , vol.304 , pp. 967-975
- Domchek, S.M.¹ Friebel, T.M.² Singer, C.F.³

20
- 0033199926
- Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers
- TR Rebbeck AM Levin A Eisen, et al. 1999 Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers J Natl Cancer Inst 91 1475 1479 10469748 10.1093/jnci/91.17.1475 1:STN:280: DyaK1MvgtVyisw%3D%3D (Pubitemid 29424552)
- (1999) Journal of the National Cancer Institute , vol.91 , Issue.17 , pp. 1475-1479
- Rebbeck, T.R.¹ Levin, A.M.² Eisen, A.³ Snyder, C.⁴ Watson, P.⁵ Cannon-Albright, L.⁶ Isaacs, C.⁷ Olopade, O.⁸ Garber, J.E.⁹ Godwin, A.K.¹⁰ Daly, M.B.¹¹ Narod, S.A.¹² Neuhausen, S.L.¹³ Lynch, H.T.¹⁴ Weber, B.L.¹⁵

21
- 29144522408
- Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: An International Case-Control Study
- DOI 10.1200/JCO.2004.00.7138
- A Eisen J Lubinski J Klijn, et al. 2005 Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study J Clin Oncol 23 7491 7496 16234515 10.1200/JCO.2004.00.7138 (Pubitemid 46291812)
- (2005) Journal of Clinical Oncology , vol.23 , Issue.30 , pp. 7491-7496
- Eisen, A.¹ Lubinski, J.² Klijn, J.³ Moller, P.⁴ Lynch, H.T.⁵ Offit, K.⁶ Weber, B.⁷ Rebbeck, T.⁸ Neuhausen, S.L.⁹ Ghadirian, P.¹⁰ Foulkes, W.D.¹¹ Gershoni-Baruch, R.¹² Friedman, E.¹³ Rennert, G.¹⁴ Wagner, T.¹⁵ Isaacs, C.¹⁶ Kim-Sing, C.¹⁷ Ainsworth, P.¹⁸ Sun, P.¹⁹ Narod, S.A.²⁰ more..

22
- 59049091281
- Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers
- 19141781 10.1093/jnci/djn442 1:CAS:528:DC%2BD1MXhtVehsbo%3D
- TR Rebbeck ND Kauff SM Domchek 2009 Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers J Natl Cancer Inst 101 80 87 19141781 10.1093/jnci/djn442 1:CAS:528:DC%2BD1MXhtVehsbo%3D
- (2009) J Natl Cancer Inst , vol.101 , pp. 80-87
- Rebbeck, T.R.¹ Kauff, N.D.² Domchek, S.M.³

23
- 0036341143
- A significant response to neoadjuvant chemotherapy in BRCA1/2 related breast cancer
- PO Chappuis J Goffin N Wong, et al. 2002 A significant response to neoadjuvant chemotherapy in BRCA1/2 related breast cancer J Med Genet 39 608 610 12161606 10.1136/jmg.39.8.608 1:STN:280:DC%2BD38vgvVKrug%3D%3D (Pubitemid 34864568)
- (2002) Journal of Medical Genetics , vol.39 , Issue.8 , pp. 608-610
- Chappuis, P.O.¹ Goffin, J.² Wong, N.³ Perret, C.⁴ Ghadirian, P.⁵ Tonin, P.N.⁶ Foulkes, W.D.⁷

24
- 67749097987
- Familial breast cancer: Clinical response to induction chemotherapy or radiotherapy related to BRCA1/2 mutations status
- 19307946 10.1097/COC.0b013e31817f9e1c 1:CAS:528:DC%2BD1MXktVKitbo%3D
- A Fourquet D Stoppa-Lyonnet YM Kirova, et al. 2009 Familial breast cancer: clinical response to induction chemotherapy or radiotherapy related to BRCA1/2 mutations status Am J Clin Oncol 32 127 131 19307946 10.1097/COC.0b013e31817f9e1c 1:CAS:528:DC%2BD1MXktVKitbo%3D
- (2009) Am J Clin Oncol , vol.32 , pp. 127-131
- Fourquet, A.¹ Stoppa-Lyonnet, D.² Kirova, Y.M.³

25
- 70249104279
- Long-term outcome after neo-adjuvant chemotherapy for breast cancer in BRCA1/2 carriers
- 19618461 10.1002/ijc.24596
- A Wong Wong Keet M Al-Rafae PO Chappuis JS Brunet P Ghadirian WD Foulkes 2009 Long-term outcome after neo-adjuvant chemotherapy for breast cancer in BRCA1/2 carriers Int J Cancer 125 2236 2238 19618461 10.1002/ijc.24596
- (2009) Int J Cancer , vol.125 , pp. 2236-2238
- Wong Wong Keet, A.¹ Al-Rafae, M.² Chappuis, P.O.³ Brunet, J.S.⁴ Ghadirian, P.⁵ Foulkes, W.D.⁶

26
- 9744263911
- The role of BRCA1 in the cellular response to chemotherapy
- DOI 10.1093/jnci/djh312
- RD Kennedy JE Quinn PB Mullan PG Johnston DP Harkin 2004 The role of BRCA1 in the cellular response to chemotherapy J Natl Cancer Inst 96 1659 1668 15547178 10.1093/jnci/djh312 1:CAS:528:DC%2BD2cXhtVSqsrzO (Pubitemid 39585635)
- (2004) Journal of the National Cancer Institute , vol.96 , Issue.22 , pp. 1659-1668
- Kennedy, R.D.¹ Quinn, J.E.² Mullan, P.B.³ Johnston, P.G.⁴ Harkin, D.P.⁵

27
- 0034604716
- The Breast Cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross-linking agent cisplatin
- DOI 10.1074/jbc.C000276200
- A Bhattacharyya US Ear BH Koller RR Weichselbaum DK Bishop 2000 The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross-linking agent cisplatin J Biol Chem 275 23899 23903 10843985 10.1074/jbc.C000276200 1:CAS:528:DC%2BD3cXls12lsrk%3D (Pubitemid 30624678)
- (2000) Journal of Biological Chemistry , vol.275 , Issue.31 , pp. 23899-23903
- Bhattacharyya, A.¹ Ear, U.S.² Koller, B.H.³ Weichselbaum, R.R.⁴ Bishop, D.K.⁵

28
- 0034721885
- BRCA1 facilitates stress-induced apoptosis in breast and ovarian cancer cell lines
- 10938285 10.1074/jbc.M005824200 1:CAS:528:DC%2BD3cXnvVyjsrs%3D
- M Thangaraju SH Kaufmann FJ Couch 2000 BRCA1 facilitates stress-induced apoptosis in breast and ovarian cancer cell lines J Biol Chem 275 33487 33496 10938285 10.1074/jbc.M005824200 1:CAS:528:DC%2BD3cXnvVyjsrs%3D
- (2000) J Biol Chem , vol.275 , pp. 33487-33496
- Thangaraju, M.¹ Kaufmann, S.H.² Couch, F.J.³

29
- 0033749946
- Low expression of bcl-2 in Brca1-associated breast cancers
- 11044356 10.1054/bjoc.2000.1438 1:CAS:528:DC%2BD3cXos12hu7g%3D
- P Freneaux D Stoppa-Lyonnet E Mouret, et al. 2000 Low expression of bcl-2 in Brca1-associated breast cancers Br J Cancer 83 1318 1322 11044356 10.1054/bjoc.2000.1438 1:CAS:528:DC%2BD3cXos12hu7g%3D
- (2000) Br J Cancer , vol.83 , pp. 1318-1322
- Freneaux, P.¹ Stoppa-Lyonnet, D.² Mouret, E.³

30
- 0141954010
- BRCA1 functions as a differential modulator of chemotherapy-induced apoptosis
- JE Quinn RD Kennedy PB Mullan, et al. 2003 BRCA1 functions as a differential modulator of chemotherapy-induced apoptosis Cancer Res 6319 6221 6228 (Pubitemid 37255167)
- (2003) Cancer Research , vol.63 , Issue.19 , pp. 6221-6228
- Quinn, J.E.¹ Kennedy, R.D.² Mullan, P.B.³ Gilmore, P.M.⁴ Carty, M.⁵ Johnston, P.G.⁶ Harkin, D.P.⁷

31
- 75749143502
- Pathologic complete response rates in young women with BRCA1-positive breast cancers after neoadjuvant chemotherapy
- 20008645 10.1200/JCO.2008.20.7019 1:CAS:528:DC%2BC3cXivFart74%3D
- T Byrski J Gronwald T Huzarski E Grzybowska M Budryk M Stawicka T Mierzwa M Szwiec R Wisniowski M Siolek R Dent J Lubinski S Narod 2010 Pathologic complete response rates in young women with BRCA1-positive breast cancers after neoadjuvant chemotherapy J Clin Oncol 28 375 379 20008645 10.1200/JCO.2008.20. 7019 1:CAS:528:DC%2BC3cXivFart74%3D
- (2010) J Clin Oncol , vol.28 , pp. 375-379
- Byrski, T.¹ Gronwald, J.² Huzarski, T.³ Grzybowska, E.⁴ Budryk, M.⁵ Stawicka, M.⁶ Mierzwa, T.⁷ Szwiec, M.⁸ Wisniowski, R.⁹ Siolek, M.¹⁰ Dent, R.¹¹ Lubinski, J.¹² Narod, S.¹³

33
- 34547661993
- Triple-negative breast cancer: Clinical features and patterns of recurrence
- DOI 10.1158/1078-0432.CCR-06-3045
- R Dent M Trudeau KI Pritchard WM Hanna HK Kahn CA Sawka LA Lickley E Rawlinson P Sun SA Narod 2007 Triple-negative breast cancer: clinical features and patterns of recurrence Clin Cancer Res 13 4429 4434 17671126 10.1158/1078-0432.CCR-06-3045 (Pubitemid 47219710)
- (2007) Clinical Cancer Research , vol.13 , Issue.15 , pp. 4429-4434
- Dent, R.¹ Trudeau, M.² Pritchard, K.I.³ Hanna, W.M.⁴ Kahn, H.K.⁵ Sawka, C.A.⁶ Lickley, L.A.⁷ Rawlinson, E.⁸ Sun, P.⁹ Narod, S.A.¹⁰

34
- 36849043178
- Reducing second breast cancers: A potential role for prophylactic mammary irradiation
- DOI 10.1200/JCO.2007.11.0379
- DJ Brenner I Shuryak 2007 Reducing second primary breast cancers: a potential role for prophylactic mammary irradiation J Clin Oncol 25 4868 4872 17971581 10.1200/JCO.2007.11.0379 (Pubitemid 350220415)
- (2007) Journal of Clinical Oncology , vol.25 , Issue.31 , pp. 4868-4872
- Brenner, D.J.¹ Shuryak, I.² Russo, S.³ Sachs, R.K.⁴

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.